This is why the hit came as this has become obvious. BP trying to hold this down because they know the money in being the only approved drug is. CytoDyn starting to attract attention for sure


Also attracting attention is biotech CytoDyn, which has now reached the requisite number of patients in its Phase 3 trial of leronlimab for COVID-19 ...


https://finance.yahoo.com/news/wednesday-pre-...13771.html